The bill gives the FDA authority to prevent drug shortages and speed reviews of medical devices, and also ensures the safety of drugs imported from abroad through the collection of fees from companies. Those fees will fund FDA inspections of foreign facilities and give drugmakers incentives to produce antibiotics to treat troublesome conditions.
The Senate recently passed its own FDA authorization bill, which is similar to the one the House passed but different on several fronts. The bills disagree on some medical device safety provisions and which antibiotics should qualify for incentives. Further, the Senate version includes room for a law that would implement a national system for tracking medications to cut down on fake or stolen drugs.
More Articles on the FDA:
Senate Passes FDA Safety and Innovation Act
Teleflex Receives FDA Clearance for Epidural Catheter
FDA Guidance Seeks to Reduce Radiation Exposure to Children
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
